Gluconolactone

CHEMBL1200829 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
178.1 g/mol
LogP
-2.0
Phase
4

A mild chemical exfoliant used in skincare products to remove dead skin cells and improve skin texture. It also has antioxidant properties and can help reduce the appearance of fine lines.

Moleküler Ağırlık

178,1400 g/mol

LogP

-2,00

TPSA

107,00 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

InChI

InChI=1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-5,7-10H,1H2/t2-,3-,4+,5-/m1/s1

Molecular Formula

C6H10O6

HBD / HBA

4 / 6

Döndürülebilir Bağlar

1

Ağır Atomlar

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A mild chemical exfoliant used in skincare products to remove dead skin cells and improve skin texture. It also has antioxidant properties and can help reduce the appearance of fine lines.

Yes, Gluconolactone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200829. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 7027. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.